Search Results - "Gerhardt, Lara"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy by Krishnamoorthy, Mithunah, Gerhardt, Lara, Maleki Vareki, Saman

    Published in Cells (Basel, Switzerland) (11-05-2021)
    “…The primary function of myeloid cells is to protect the host from infections. However, during cancer progression or states of chronic inflammation, these cells…”
    Get full text
    Journal Article
  2. 2

    587 Inducing mismatch repair deficiency in combination with anti-CTLA4 therapy is highly effective against non-immunogenic neuroblastoma tumors by El-Hajjar, Mikal, Gerhardt, Lara, Krishnamoorthy, Mithunah, Figueredo, Rene, Zheng, Xiufen, Koropatnick, James, Maleki, Saman

    Published in Journal for immunotherapy of cancer (01-11-2021)
    “…BackgroundDespite rigorous multimodal therapy, recurrence is common among high-risk neuroblastoma patients. Neuroblastoma is a poorly immunogenic tumor with…”
    Get full text
    Journal Article
  3. 3

    IL-12 and IL-27 Promote CD39 Expression on CD8+ T Cells and Differentially Regulate the CD39+CD8+ T Cell Phenotype by Gerhardt, Lara, Hong, Megan M Y, Yousefi, Yeganeh, Figueredo, Rene, Maleki Vareki, Saman

    Published in The Journal of immunology (1950) (15-05-2023)
    “…Tumor-specific CD8+ T cells are critical components of antitumor immunity; however, factors that modulate their phenotype and function have not been completely…”
    Get full text
    Journal Article
  4. 4

    1028 IL-12 and IL-27 upregulate CD39 expression on CD8+ T-cells and differentially affect CD39+CD8+ T-cell effector function by Gerhardt, Lara, Figueredo, Rene, Maleki, Saman

    Published in Journal for immunotherapy of cancer (01-11-2022)
    “…BackgroundTumor-specific CD8+ T-cells play a critical role in tumor control, as demonstrated by the success of immune checkpoint inhibitors and adoptive cell…”
    Get full text
    Journal Article
  5. 5

    Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory by El-Hajjar, Mikal, Gerhardt, Lara, Hong, Megan M Y, Krishnamoorthy, Mithunah, Figueredo, Rene, Zheng, Xiufen, Koropatnick, James, Maleki Vareki, Saman

    Published in Molecular therapy (01-02-2023)
    “…Immune checkpoint blockade can induce potent and durable responses in patients with highly immunogenic mismatch repair-deficient tumors; however, these drugs…”
    Get full text
    Journal Article